Global Small Molecule Targeted Therapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 104 pages | ID: G6C9AE417CA8EN
LP Information

Abstracts

According to this study, the global Small Molecule Targeted Therapy market size will reach US$ million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Small Molecule Targeted Therapy Industry Forecast” looks at past sales and reviews total world Small Molecule Targeted Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Small Molecule Targeted Therapy sales for 2025 through 2031. With Small Molecule Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Targeted Therapy industry.

This Insight Report provides a comprehensive analysis of the global Small Molecule Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Molecule Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Molecule Targeted Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Targeted Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Targeted Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Targeted Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• TKI
• Multitarget Inhibitor
• Others

Segmentation by Application:

• Liver Cancer
• Colorectal Cancer
• Lung Cancer
• Gastric Cancer
• Breast Cancer
• Esophageal Cancer
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Astrazeneca
• Novartis
• Millennium Pharmaceuticals
• Bayer
• Exelixis
• Abbvie
• Boehringer-Ingelheim
• Eisai
• Pfizer
• Bristol-Myers Squibb
• Roche
• Bettapharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Small Molecule Targeted Therapy Market Size (2020-2031)
  2.1.2 Small Molecule Targeted Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Small Molecule Targeted Therapy by Country/Region (2020, 2024 & 2031)
2.2 Small Molecule Targeted Therapy Segment by Type
  2.2.1 TKI
  2.2.2 Multitarget Inhibitor
  2.2.3 Others
2.3 Small Molecule Targeted Therapy Market Size by Type
  2.3.1 Small Molecule Targeted Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Small Molecule Targeted Therapy Market Size Market Share by Type (2020-2025)
2.4 Small Molecule Targeted Therapy Segment by Application
  2.4.1 Liver Cancer
  2.4.2 Colorectal Cancer
  2.4.3 Lung Cancer
  2.4.4 Gastric Cancer
  2.4.5 Breast Cancer
  2.4.6 Esophageal Cancer
  2.4.7 Others
2.5 Small Molecule Targeted Therapy Market Size by Application
  2.5.1 Small Molecule Targeted Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Small Molecule Targeted Therapy Market Size Market Share by Application (2020-2025)

3 SMALL MOLECULE TARGETED THERAPY MARKET SIZE BY PLAYER

3.1 Small Molecule Targeted Therapy Market Size Market Share by Player
  3.1.1 Global Small Molecule Targeted Therapy Revenue by Player (2020-2025)
  3.1.2 Global Small Molecule Targeted Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Small Molecule Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SMALL MOLECULE TARGETED THERAPY BY REGION

4.1 Small Molecule Targeted Therapy Market Size by Region (2020-2025)
4.2 Global Small Molecule Targeted Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Small Molecule Targeted Therapy Market Size Growth (2020-2025)
4.4 APAC Small Molecule Targeted Therapy Market Size Growth (2020-2025)
4.5 Europe Small Molecule Targeted Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Small Molecule Targeted Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Small Molecule Targeted Therapy Market Size by Country (2020-2025)
5.2 Americas Small Molecule Targeted Therapy Market Size by Type (2020-2025)
5.3 Americas Small Molecule Targeted Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Small Molecule Targeted Therapy Market Size by Region (2020-2025)
6.2 APAC Small Molecule Targeted Therapy Market Size by Type (2020-2025)
6.3 APAC Small Molecule Targeted Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Small Molecule Targeted Therapy Market Size by Country (2020-2025)
7.2 Europe Small Molecule Targeted Therapy Market Size by Type (2020-2025)
7.3 Europe Small Molecule Targeted Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Small Molecule Targeted Therapy by Region (2020-2025)
8.2 Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SMALL MOLECULE TARGETED THERAPY MARKET FORECAST

10.1 Global Small Molecule Targeted Therapy Forecast by Region (2026-2031)
  10.1.1 Global Small Molecule Targeted Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Small Molecule Targeted Therapy Forecast
  10.1.3 APAC Small Molecule Targeted Therapy Forecast
  10.1.4 Europe Small Molecule Targeted Therapy Forecast
  10.1.5 Middle East & Africa Small Molecule Targeted Therapy Forecast
10.2 Americas Small Molecule Targeted Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Small Molecule Targeted Therapy Forecast
  10.2.2 Canada Market Small Molecule Targeted Therapy Forecast
  10.2.3 Mexico Market Small Molecule Targeted Therapy Forecast
  10.2.4 Brazil Market Small Molecule Targeted Therapy Forecast
10.3 APAC Small Molecule Targeted Therapy Forecast by Region (2026-2031)
  10.3.1 China Small Molecule Targeted Therapy Market Forecast
  10.3.2 Japan Market Small Molecule Targeted Therapy Forecast
  10.3.3 Korea Market Small Molecule Targeted Therapy Forecast
  10.3.4 Southeast Asia Market Small Molecule Targeted Therapy Forecast
  10.3.5 India Market Small Molecule Targeted Therapy Forecast
  10.3.6 Australia Market Small Molecule Targeted Therapy Forecast
10.4 Europe Small Molecule Targeted Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Small Molecule Targeted Therapy Forecast
  10.4.2 France Market Small Molecule Targeted Therapy Forecast
  10.4.3 UK Market Small Molecule Targeted Therapy Forecast
  10.4.4 Italy Market Small Molecule Targeted Therapy Forecast
  10.4.5 Russia Market Small Molecule Targeted Therapy Forecast
10.5 Middle East & Africa Small Molecule Targeted Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Small Molecule Targeted Therapy Forecast
  10.5.2 South Africa Market Small Molecule Targeted Therapy Forecast
  10.5.3 Israel Market Small Molecule Targeted Therapy Forecast
  10.5.4 Turkey Market Small Molecule Targeted Therapy Forecast
10.6 Global Small Molecule Targeted Therapy Forecast by Type (2026-2031)
10.7 Global Small Molecule Targeted Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Small Molecule Targeted Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Astrazeneca
  11.1.1 Astrazeneca Company Information
  11.1.2 Astrazeneca Small Molecule Targeted Therapy Product Offered
  11.1.3 Astrazeneca Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Astrazeneca Main Business Overview
  11.1.5 Astrazeneca Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Small Molecule Targeted Therapy Product Offered
  11.2.3 Novartis Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Millennium Pharmaceuticals
  11.3.1 Millennium Pharmaceuticals Company Information
  11.3.2 Millennium Pharmaceuticals Small Molecule Targeted Therapy Product Offered
  11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Millennium Pharmaceuticals Main Business Overview
  11.3.5 Millennium Pharmaceuticals Latest Developments
11.4 Bayer
  11.4.1 Bayer Company Information
  11.4.2 Bayer Small Molecule Targeted Therapy Product Offered
  11.4.3 Bayer Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bayer Main Business Overview
  11.4.5 Bayer Latest Developments
11.5 Exelixis
  11.5.1 Exelixis Company Information
  11.5.2 Exelixis Small Molecule Targeted Therapy Product Offered
  11.5.3 Exelixis Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Exelixis Main Business Overview
  11.5.5 Exelixis Latest Developments
11.6 Abbvie
  11.6.1 Abbvie Company Information
  11.6.2 Abbvie Small Molecule Targeted Therapy Product Offered
  11.6.3 Abbvie Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Abbvie Main Business Overview
  11.6.5 Abbvie Latest Developments
11.7 Boehringer-Ingelheim
  11.7.1 Boehringer-Ingelheim Company Information
  11.7.2 Boehringer-Ingelheim Small Molecule Targeted Therapy Product Offered
  11.7.3 Boehringer-Ingelheim Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Boehringer-Ingelheim Main Business Overview
  11.7.5 Boehringer-Ingelheim Latest Developments
11.8 Eisai
  11.8.1 Eisai Company Information
  11.8.2 Eisai Small Molecule Targeted Therapy Product Offered
  11.8.3 Eisai Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Eisai Main Business Overview
  11.8.5 Eisai Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Small Molecule Targeted Therapy Product Offered
  11.9.3 Pfizer Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 Bristol-Myers Squibb
  11.10.1 Bristol-Myers Squibb Company Information
  11.10.2 Bristol-Myers Squibb Small Molecule Targeted Therapy Product Offered
  11.10.3 Bristol-Myers Squibb Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Bristol-Myers Squibb Main Business Overview
  11.10.5 Bristol-Myers Squibb Latest Developments
11.11 Roche
  11.11.1 Roche Company Information
  11.11.2 Roche Small Molecule Targeted Therapy Product Offered
  11.11.3 Roche Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Roche Main Business Overview
  11.11.5 Roche Latest Developments
11.12 Bettapharma
  11.12.1 Bettapharma Company Information
  11.12.2 Bettapharma Small Molecule Targeted Therapy Product Offered
  11.12.3 Bettapharma Small Molecule Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Bettapharma Main Business Overview
  11.12.5 Bettapharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Small Molecule Targeted Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Small Molecule Targeted Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of TKI
Table 4. Major Players of Multitarget Inhibitor
Table 5. Major Players of Others
Table 6. Small Molecule Targeted Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Small Molecule Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Small Molecule Targeted Therapy Market Size Market Share by Type (2020-2025)
Table 9. Small Molecule Targeted Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Small Molecule Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Small Molecule Targeted Therapy Market Size Market Share by Application (2020-2025)
Table 12. Global Small Molecule Targeted Therapy Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Small Molecule Targeted Therapy Revenue Market Share by Player (2020-2025)
Table 14. Small Molecule Targeted Therapy Key Players Head office and Products Offered
Table 15. Small Molecule Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small Molecule Targeted Therapy Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Small Molecule Targeted Therapy Market Size Market Share by Region (2020-2025)
Table 20. Global Small Molecule Targeted Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Small Molecule Targeted Therapy Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Small Molecule Targeted Therapy Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Small Molecule Targeted Therapy Market Size Market Share by Country (2020-2025)
Table 24. Americas Small Molecule Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Small Molecule Targeted Therapy Market Size Market Share by Type (2020-2025)
Table 26. Americas Small Molecule Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Small Molecule Targeted Therapy Market Size Market Share by Application (2020-2025)
Table 28. APAC Small Molecule Targeted Therapy Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Small Molecule Targeted Therapy Market Size Market Share by Region (2020-2025)
Table 30. APAC Small Molecule Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Small Molecule Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Small Molecule Targeted Therapy Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Small Molecule Targeted Therapy Market Size Market Share by Country (2020-2025)
Table 34. Europe Small Molecule Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Small Molecule Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Small Molecule Targeted Therapy Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Small Molecule Targeted Therapy
Table 40. Key Market Challenges & Risks of Small Molecule Targeted Therapy
Table 41. Key Industry Trends of Small Molecule Targeted Therapy
Table 42. Global Small Molecule Targeted Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Small Molecule Targeted Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Small Molecule Targeted Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Small Molecule Targeted Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Astrazeneca Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 47. Astrazeneca Small Molecule Targeted Therapy Product Offered
Table 48. Astrazeneca Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Astrazeneca Main Business
Table 50. Astrazeneca Latest Developments
Table 51. Novartis Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 52. Novartis Small Molecule Targeted Therapy Product Offered
Table 53. Novartis Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments
Table 56. Millennium Pharmaceuticals Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 57. Millennium Pharmaceuticals Small Molecule Targeted Therapy Product Offered
Table 58. Millennium Pharmaceuticals Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Millennium Pharmaceuticals Main Business
Table 60. Millennium Pharmaceuticals Latest Developments
Table 61. Bayer Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 62. Bayer Small Molecule Targeted Therapy Product Offered
Table 63. Bayer Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Bayer Main Business
Table 65. Bayer Latest Developments
Table 66. Exelixis Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 67. Exelixis Small Molecule Targeted Therapy Product Offered
Table 68. Exelixis Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Exelixis Main Business
Table 70. Exelixis Latest Developments
Table 71. Abbvie Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 72. Abbvie Small Molecule Targeted Therapy Product Offered
Table 73. Abbvie Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Abbvie Main Business
Table 75. Abbvie Latest Developments
Table 76. Boehringer-Ingelheim Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 77. Boehringer-Ingelheim Small Molecule Targeted Therapy Product Offered
Table 78. Boehringer-Ingelheim Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Boehringer-Ingelheim Main Business
Table 80. Boehringer-Ingelheim Latest Developments
Table 81. Eisai Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 82. Eisai Small Molecule Targeted Therapy Product Offered
Table 83. Eisai Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Eisai Main Business
Table 85. Eisai Latest Developments
Table 86. Pfizer Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 87. Pfizer Small Molecule Targeted Therapy Product Offered
Table 88. Pfizer Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Bristol-Myers Squibb Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 92. Bristol-Myers Squibb Small Molecule Targeted Therapy Product Offered
Table 93. Bristol-Myers Squibb Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Bristol-Myers Squibb Main Business
Table 95. Bristol-Myers Squibb Latest Developments
Table 96. Roche Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 97. Roche Small Molecule Targeted Therapy Product Offered
Table 98. Roche Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Roche Main Business
Table 100. Roche Latest Developments
Table 101. Bettapharma Details, Company Type, Small Molecule Targeted Therapy Area Served and Its Competitors
Table 102. Bettapharma Small Molecule Targeted Therapy Product Offered
Table 103. Bettapharma Small Molecule Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Bettapharma Main Business
Table 105. Bettapharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Small Molecule Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Molecule Targeted Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Small Molecule Targeted Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Small Molecule Targeted Therapy Sales Market Share by Country/Region (2024)
Figure 8. Small Molecule Targeted Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Small Molecule Targeted Therapy Market Size Market Share by Type in 2024
Figure 10. Small Molecule Targeted Therapy in Liver Cancer
Figure 11. Global Small Molecule Targeted Therapy Market: Liver Cancer (2020-2025) & ($ millions)
Figure 12. Small Molecule Targeted Therapy in Colorectal Cancer
Figure 13. Global Small Molecule Targeted Therapy Market: Colorectal Cancer (2020-2025) & ($ millions)
Figure 14. Small Molecule Targeted Therapy in Lung Cancer
Figure 15. Global Small Molecule Targeted Therapy Market: Lung Cancer (2020-2025) & ($ millions)
Figure 16. Small Molecule Targeted Therapy in Gastric Cancer
Figure 17. Global Small Molecule Targeted Therapy Market: Gastric Cancer (2020-2025) & ($ millions)
Figure 18. Small Molecule Targeted Therapy in Breast Cancer
Figure 19. Global Small Molecule Targeted Therapy Market: Breast Cancer (2020-2025) & ($ millions)
Figure 20. Small Molecule Targeted Therapy in Esophageal Cancer
Figure 21. Global Small Molecule Targeted Therapy Market: Esophageal Cancer (2020-2025) & ($ millions)
Figure 22. Small Molecule Targeted Therapy in Others
Figure 23. Global Small Molecule Targeted Therapy Market: Others (2020-2025) & ($ millions)
Figure 24. Global Small Molecule Targeted Therapy Market Size Market Share by Application in 2024
Figure 25. Global Small Molecule Targeted Therapy Revenue Market Share by Player in 2024
Figure 26. Global Small Molecule Targeted Therapy Market Size Market Share by Region (2020-2025)
Figure 27. Americas Small Molecule Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 28. APAC Small Molecule Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 29. Europe Small Molecule Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 30. Middle East & Africa Small Molecule Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 31. Americas Small Molecule Targeted Therapy Value Market Share by Country in 2024
Figure 32. United States Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. Canada Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Mexico Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Brazil Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. APAC Small Molecule Targeted Therapy Market Size Market Share by Region in 2024
Figure 37. APAC Small Molecule Targeted Therapy Market Size Market Share by Type (2020-2025)
Figure 38. APAC Small Molecule Targeted Therapy Market Size Market Share by Application (2020-2025)
Figure 39. China Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Japan Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. South Korea Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Southeast Asia Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. India Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Australia Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Europe Small Molecule Targeted Therapy Market Size Market Share by Country in 2024
Figure 46. Europe Small Molecule Targeted Therapy Market Size Market Share by Type (2020-2025)
Figure 47. Europe Small Molecule Targeted Therapy Market Size Market Share by Application (2020-2025)
Figure 48. Germany Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. France Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. UK Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Italy Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 52. Russia Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Middle East & Africa Small Molecule Targeted Therapy Market Size Market Share by Region (2020-2025)
Figure 54. Middle East & Africa Small Molecule Targeted Therapy Market Size Market Share by Type (2020-2025)
Figure 55. Middle East & Africa Small Molecule Targeted Therapy Market Size Market Share by Application (2020-2025)
Figure 56. Egypt Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. South Africa Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 58. Israel Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 59. Turkey Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 60. GCC Countries Small Molecule Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 61. Americas Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 62. APAC Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 63. Europe Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 64. Middle East & Africa Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 65. United States Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 66. Canada Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 67. Mexico Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 68. Brazil Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 69. China Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 70. Japan Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 71. Korea Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 72. Southeast Asia Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 73. India Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 74. Australia Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 75. Germany Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 76. France Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 77. UK Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 78. Italy Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 79. Russia Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 80. Egypt Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 81. South Africa Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 82. Israel Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 83. Turkey Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 84. Global Small Molecule Targeted Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 85. Global Small Molecule Targeted Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 86. GCC Countries Small Molecule Targeted Therapy Market Size 2026-2031 ($ millions)